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OL-001 Proliferation and anti-apoptosis induced by
actinomycin D and tumor necrosis factor-α in
HepG2 cells stably transfected with the F protein
of hepatitis C virus subtype 1b
Jingjing Yang*,1,2, Yun Zhang1, Xiaozhao Deng1,
Zhongcan Wang1, Jie Wang2, Le Feng3, Weiliang Ding3.
1Institute of Militalry Medicine, Nanjing Command, Nanjing,
China; 2Department of Epidemiology, Nanjing Medical
University, Nanjing, China; 3Yixing People’s Hospital, Yixing,
China
Objective: To investigate the effects of the F protein of Hepatitis
C virus subtype 1b on the apoptosis of human hepatocellular
carcinom HepG2 cells.
Methods: HepG2 cells were transfected with recombinant plas-
mid pcDNA3.0-F-EGFP. And pcDNA3.0-F-EGFP-HepG2 strain was
exposed to Actinomycin D and tumor necrosis factor α treatment
to induce cell apoptosis with positive control pcDNA3.0-C-EGFP-
HepG2, negative control pcDNA3.0-C-EGFP-HepG2 and blank con-
trol HepG2. Annexin V-FITC/PI of Flow cytometry was performed
to determine the number of apoptotic cells. DNA Ladder was
used to observe the isolation of apoptotic DNA fragments in the
apoptotic cells.
Results: pcDNA3.0-F-EGFP- HepG2 cell strain showed a much
delayed apoptosis as well as obviously lowered apoptotic rate
in comparison with the pcDNA3.0-HepG2 strain and HepG2 strain
(P<0.001).
Fig. 1. Apoptosis of HepG2 cells in four groups treated for 48 hours with
Act-D, TNFα. I. Apoptosis of HepG2 of F group, 62.44%; II. Apoptosis of
HepG2 of C group, 48.7%; III. Apoptosis of HepG2 of Negative group, 95.3%;
IV. Apoptosis of HepG2 of Blank control group, 94.52%.
Fig. 2. Temporal changes of the cell apoptotic rate in four groups. Mean
values of the four groups for each condition and standard deviations are
shown.
Conclusion: The F gene of Hepatitis C virus subtype 1b signiﬁ-
cantly inhibits the apoptosis of HepG2 cells.
OL-002 The inﬂuence of HCV-F protein on the expression
of PI3K in HCV infected patients
Wenjuan Yao1, Xiaozhao Deng*,2, Jingjing Yang3, Lili Dong3,
Yun Zhang2. 1Institute of Life Science, China Pharmaceutical
University; 2Institute of Militalry Medicine, Nanjing Command;
3Nanjing Medical University
Objectives: To demonstrate the role of HCV-F (Hepatitis C virus)
protein on the pathogenic mechanism of chronic hepatitis C,
especially on cell signal pathway.
Methods: PBMCs (peripheral blood mononuclear cells) from
twenty-eight HCV infected patients and ten healthy volunteers
were separated. The total proteins were quantitated by BradFord
assay and separated by the immobilized pH gradient-based 2-DE.
The differentially expressed proteins were screened by PDQuest
analysis software. PMF (peptide mass ﬁngerprint) was obtained
by MALDI-TOF-MS (matrix-assisted laser desorption/ionization
time of ﬂight mass spectrometry). Proteins were identiﬁed by
searching SWISS-PROT. The recombinant vector pcDNA3.0(–)-F
containing F gene and the control vector pcDNA3.0(–) were
transfected into HepG2 cells using Lipofectamin2000. Then RT-
PCR and Western blot analysis were performed.
Results: 2-DE results showed that the mean number of protein
spots in HCV infected patients and healthy persons were 625
and 614, respectively (Fig. 1). Twelve differential proteins were
tested by MALDI-TOF-MS, and ten of them were identiﬁed includ-
ing HCV-F protein and some proteins participated in cell signal
pathway. HCV-F protein was successfully expressed in HepG2
cells. Meanwhile, the expression of PI3K protein was detected in
a high level in the pcDNA3.0(–)-F infected HepG2 cells (Fig. 2).
Conclusion: The expression of HCV-F protein in infected cells has
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Fig. 1. The matching result of 2-D gel map of proteins from PBMC of HCV
infected patients and healthy persons.
Fig. 2. Detecting F protein and PI3K by Western blot analysis. M: Protein
marker; 1, 4, 5: pcDNA3.0-HepG2; 2, 3, 6: pcDNA3.0-F-HepG2.
signiﬁcant inﬂuence on cell signal pathway. HCV-F protein can
activate PI3K protein and its signal cascade pathway. Therefore,
HCV-F protein may plays an important role in HCV pathogenesis.
OL-003 Secretion of hepatitis C virus E2 protein could
enhance neutralization antibodies induced by
DNA vaccine
Zhi-hui Chen1, Yi-min Tong2, Zhong-tian Qi *,2. 1Department of
Infectious Diseases, Changhai Hospital, Second Military Medical
University, Shanghai, China; 2Department of Microbiology,
Second Military Medical University, Shanghai, China
Objective: To explore the feasibility of induction of neutraliza-
tion antibodies against HCV infection by DNA vaccines.
Methods: Two expression plasmids of HCV envelope 2 protein
were constructed, plasmid pCI-1b746 encoding full length of E2
protein, and plasmid pCI-1b661 encoding hydrophobic carboxyl
terminal truncated E2. 293T cells were transfected with either
of both plasmids, respectively, and intracellular and secreted E2
protein were analyzed by Western blot or immunoﬂuorescence.
Then the plasmids were used to immunize BALB/c mouse in-
tramusclarly. The sera antibodies against E2 and hypervariable
region 1 (HVR1) were detected by ELISA and the neutralization
activity of the sera were assayed with HCV pseudotype particle
(HCVpp).
Results: Both plasmids could express HCV E2 protein, the ex-
pression product of pCI-1b746 could not secrete, while that of
pCI-1b661 could secrete into culture medium. The secretion of
HCV E2 protein enhanced antibody response elicited by DNA vac-
cines in mice signiﬁcantly. Sera from pCI-1b661 immunized mice
showed stronger neutralization activity than that from pCI-1b746
immunized mice. For sera from pCI-1b661 immunized mice, the
neutralization activity against HCVpp were positive correlation
with anti-HVR1 antibodies levels.
Conclusions: Secretion of E2 protein by DNA vaccine can enhance
the production of neutralization antibodies against HCVpp infec-
tion and the neutralizing activity is depended on the presence of
HVR1 antibodies.
OL-004 Suppression of liver ﬁbrosis is associated with the
decrease of transforming growth factor-β1 and
increase of matrix metalloproteinase-1
expression after interferon-α therapy in chronic
hepatitis C patients
Yun-ru Li *. Beijing Ditan Hospital, Beijing, China
Aim: To evaluated relationship of the changes of transforming
growth factor-β1 (TGF-β), matrix metalloproteinase-1 (MMP-1)
and tissue inhibitors of matrix metalloproteinase-1 (TIMP-1) ex-
pression with liver ﬁbrosis in liver tissue after IFN-α therapy in
patients with chronic hepatitis C.
Methods: Eleven patients with chronic hepatitis C treated by
IFN-α were divided into two groups on the outcome of therapy,
including a complete responder group (CR) and a non-responder
group (NR). Liver biopsy specimens were stained with hema-
toxylin and eosin (HE) and Masson’s trichrome staining. Liver
ﬁbrosis was semiquantitated by Modiﬁed Ishak scoring system.
Results: There was a signiﬁcant reduction in Ishak ﬁbrosis score
in SVR group (P<0.05). The TGF-β1 expression was reduced and
the MMP-1 expression was elevated in SVR groups after IFN-α
therapy (P<0.05). The ratio of the density of MMP-1 to TIMP-1
expression increased in SVR group after IFN-α therapy compared
with NR group (P<0.05). The reduction of ﬁbrosis score corre-
lated signiﬁcantly with that of TGF-β1 expression in all patients
(R=0.744, P<0.01). The increase of MMP-1 expression after IFN-α
therapy signiﬁcantly correlated with the decrease of ﬁbrosis
(R=-0.925, P<0.05) and HAI (R=-0.837, P<0.05) scores in SVR
group.
Conclusion: IFN-α improves liver ﬁbrosis in hepatitis C patients
by decreasing TGF-β1 expression, as well as by increasing MMP-1
expression to degrade ﬁbrosis.
OL-005 Immunohistochemical study of hepatic oval cells
in fetal liver and chronic C hepatitis
Maria Comanescu*,1, Violeta Comanescu2. 1University Clinical
Hospital of Bucharest, Romania; 2County Clinical Hospital of
Craiova, Romania
Background: Hepatic oval cells differentiate into two types of
cells, hepatocytes and biliary cells. The aim of this study was to
identify oval cells in fetal liver and in adult liver from patients
with chronic C hepatitis.
Method: This study was performed using two study group. The
ﬁrst included 10 human fetal livers from embryos from ther-
apeutical abortions with gestational ages ranging betwwen 10
and 21 weeks. The second group included 30 liver biopsies from
patients with viral C hepatitis. The liver specimens were ﬁxed
in formaldehyde, embedded in parafﬁn and cut at 5 μm. Slides
were stained using standard (HE, VG) and immunohistochemical
stainings (CK19, CD45, alfaSMA and desmin).
Results: All cases were examined by light microscopy. Oval cells
were identiﬁed as small cells with basophilic cytoplasm and
small oval nuclei, located in periportal areas, and in association
with ﬁbrosis and inﬂammation. They were positive for CK19 and
negative for CD45. Desmin was positive in fetal hepatocytes and
negative in adult hepatocytes. Alfa SMA was positive in periportal
cells and negative in hepatocytes and biliar ducts. In chronic C
hepatitis alfa SMA was positive in isolated cells in the areas of
necrosis.
